Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal’s manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal’s R & D facilities are located in Pune.
Financial Results:
Hikal Ltd reported Revenues for Q1FY25 of ₹406.80 Crores up from ₹388.00 Crore year on year, a rise of 4.85%.
Total Expenses for Q1FY25 of ₹400.40 Crores up from ₹379.20 Crores year on year, a rise of 5.59%.
Consolidated Net Profit of ₹5.10 Crores down 26.09% from ₹6.90 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.41, down 26.79% from ₹0.56 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.